• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

rt-PA静脉溶栓治疗中风:摩洛哥中风单元的经验

Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit.

作者信息

Chtaou Naima, Rachdi Lamyae, Midaoui Aouatef El, Souirti Zouhair, Wahlgren Nils, Belahsen Mohammed Faouzi

机构信息

Neurology Department, Hassan II University Hospital, Fez, Morocco.

Neurology Department, Hassan II University Hospital, Fez, Morocco; Laboratory of Epidemiology and Public Health, Faculty of Medicine and Pharmacy, Sidi Mohammed BenAbdellah university Fez, Morocco.

出版信息

Pan Afr Med J. 2016 Jul 8;24:207. doi: 10.11604/pamj.2016.24.207.8815. eCollection 2016.

DOI:10.11604/pamj.2016.24.207.8815
PMID:27795802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5072866/
Abstract

The majority of strokes are due to blockage of an artery in the brain by a blood clot. Prompt treatment with thrombolytic drugs can restore blood flow before major brain damage has occurred. We report the case series of all patients who were treated with rt-PA at Stroke Unit of HASSAN II University hospital between 2010 and 2013. There were 52 patients treated with intravenous rtPA during the study period. The mean age was 63 years with the no gender predominance (sex ratio 1.02). Hypertension was the most common vascular risk factor (31%) and 17% of patients suffered from atrial fibrillation. 17 of 52 patients (32.7%) were treated within a 3 hours window of stroke onset and 35 of 52 (67.3%) patients were treated within 3-4.5 h. Twenty five patients (48%) had significant early improvements within 24 hours and twenty one (40.3%) patients had good outcomes at 3 months and fifteen patients (29%) died within the same period.

摘要

大多数中风是由于血凝块阻塞大脑中的动脉所致。在严重脑损伤发生之前,及时使用溶栓药物治疗可恢复血流。我们报告了2010年至2013年期间在哈桑二世大学医院卒中单元接受rt-PA治疗的所有患者的病例系列。研究期间有52例患者接受了静脉rtPA治疗。平均年龄为63岁,无性别优势(性别比为1.02)。高血压是最常见的血管危险因素(31%),17%的患者患有心房颤动。52例患者中有17例(32.7%)在中风发作3小时内接受治疗,52例中有35例(67.3%)患者在3至4.5小时内接受治疗。25例患者(48%)在24小时内有显著早期改善,21例(40.3%)患者在3个月时有良好预后,15例患者(29%)在同一时期死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da81/5072866/df797aad8c04/PAMJ-24-207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da81/5072866/df797aad8c04/PAMJ-24-207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da81/5072866/df797aad8c04/PAMJ-24-207-g001.jpg

相似文献

1
Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit.rt-PA静脉溶栓治疗中风:摩洛哥中风单元的经验
Pan Afr Med J. 2016 Jul 8;24:207. doi: 10.11604/pamj.2016.24.207.8815. eCollection 2016.
2
Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.多模式计算机断层扫描引导下在较长时间窗内对合并心房颤动的急性缺血性卒中患者进行溶栓治疗
Int Heart J. 2019 Jul 27;60(4):822-829. doi: 10.1536/ihj.18-636. Epub 2019 Jun 28.
3
Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.快速 MRI 指导下的清醒型缺血性卒中的重组组织型纤溶酶原激活剂研究。
Cerebrovasc Dis. 2019;48(1-2):85-90. doi: 10.1159/000503379. Epub 2019 Oct 4.
4
Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).静脉溶栓在中国对隐源性卒中安全有效:来自中国急性缺血性卒中溶栓实施与监测(TIMS-China)的数据。
J Stroke Cerebrovasc Dis. 2019 Jan;28(1):220-226. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.041. Epub 2018 Oct 23.
5
Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中的真实世界结局
J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1996-2003. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.010. Epub 2017 Jul 6.
6
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.急性缺血性脑卒中发病 6 小时内应用重组组织型纤溶酶原激活剂静脉溶栓的获益和危害(第三次国际脑卒中试验[IST-3]):一项随机对照试验。
Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23.
7
Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.急性缺血性脑卒中患者静脉溶栓后早期和持续的神经功能改善是长期预后良好的强有力预测指标。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e590-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.024. Epub 2013 Aug 15.
8
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
9
Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.静脉注射组织型纤溶酶原激活剂治疗患者的临床特征和从进入医院到开始溶栓时间的时间趋势:日本 4 家医院的回顾性研究。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104305. doi: 10.1016/j.jstrokecerebrovasdis.2019.104305. Epub 2019 Aug 10.
10
Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.在接受利伐沙班治疗的中风患者中使用重组组织型纤溶酶原激活剂进行静脉溶栓治疗。
J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):e457-e459. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.008. Epub 2014 Oct 3.

引用本文的文献

1
Prediction of Hemorrhagic Complication after Thrombolytic Therapy Based on Multimodal Data from Multiple Centers: An Approach to Machine Learning and System Implementation.基于多中心多模态数据的溶栓治疗后出血并发症预测:一种机器学习与系统实施方法
J Pers Med. 2022 Dec 12;12(12):2052. doi: 10.3390/jpm12122052.
2
A New Nomogram for Predicting the Risk of Intracranial Hemorrhage in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.一种用于预测急性缺血性卒中患者静脉溶栓后颅内出血风险的新列线图。
Front Neurol. 2022 Mar 10;13:774654. doi: 10.3389/fneur.2022.774654. eCollection 2022.
3
Stroke in Africa: profile, progress, prospects and priorities.

本文引用的文献

1
Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital.在摩洛哥一家医院急诊科使用替奈普酶进行急性缺血性卒中溶栓治疗。
Pan Afr Med J. 2015 May 19;21:37. doi: 10.11604/pamj.2015.21.37.6491. eCollection 2015.
2
Socioeconomic status and stroke prevalence in Morocco: results from the Rabat-Casablanca study.摩洛哥的社会经济地位与中风患病率:拉巴特-卡萨布兰卡研究结果
PLoS One. 2014 Feb 28;9(2):e89271. doi: 10.1371/journal.pone.0089271. eCollection 2014.
3
Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
非洲的中风:概况、进展、前景和重点。
Nat Rev Neurol. 2021 Oct;17(10):634-656. doi: 10.1038/s41582-021-00542-4. Epub 2021 Sep 15.
4
Ischemic stroke in Morocco: a systematic review.摩洛哥的缺血性中风:一项系统综述。
BMC Neurol. 2019 Dec 30;19(1):349. doi: 10.1186/s12883-019-1558-1.
5
Notes on the Recent History of Neuroscience in Africa.非洲神经科学近期历史笔记
Front Neuroanat. 2017 Nov 7;11:96. doi: 10.3389/fnana.2017.00096. eCollection 2017.
6
Interventions for acute stroke management in Africa: a systematic review of the evidence.非洲急性脑卒中管理干预措施:系统评价证据。
Syst Rev. 2017 Oct 24;6(1):213. doi: 10.1186/s13643-017-0594-4.
静脉溶栓治疗急性缺血性脑卒中发病 4.5 至 6 小时内的结果以及 3 至 4.5 小时内更新的结果记录在卒中溶栓治疗国际登记研究(SITS-ISTR):一项观察性研究。
JAMA Neurol. 2013 Jul;70(7):837-44. doi: 10.1001/jamaneurol.2013.406.
4
Barriers of thrombolysis therapy in developing countries.发展中国家溶栓治疗的障碍。
Stroke Res Treat. 2011;2011:686797. doi: 10.4061/2011/686797. Epub 2011 Mar 17.
5
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.急性缺血性卒中发病3.0 - 4.5小时后使用阿替普酶进行卒中治疗(ECASS III):一项随机对照试验的额外结局及亚组分析
Lancet Neurol. 2009 Dec;8(12):1095-102. doi: 10.1016/S1474-4422(09)70264-9. Epub 2009 Oct 21.
6
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2009 Oct 7(4):CD000213. doi: 10.1002/14651858.CD000213.pub2.
7
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.56项基于人群的研究报告的全球中风发病率和早期病死率:一项系统评价。
Lancet Neurol. 2009 Apr;8(4):355-69. doi: 10.1016/S1474-4422(09)70025-0. Epub 2009 Feb 21.
8
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.卒中溶栓监测研究(SITS-MOST)中阿替普酶用于急性缺血性卒中的溶栓治疗:一项观察性研究
Lancet. 2007 Jan 27;369(9558):275-82. doi: 10.1016/S0140-6736(07)60149-4.
9
Preventing stroke: saving lives around the world.预防中风:拯救全球生命。
Lancet Neurol. 2007 Feb;6(2):182-7. doi: 10.1016/S1474-4422(07)70031-5.
10
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.早期卒中治疗与预后的关联:ATLANTIS、ECASS及NINDS rt-PA卒中试验的汇总分析
Lancet. 2004 Mar 6;363(9411):768-74. doi: 10.1016/S0140-6736(04)15692-4.